Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4369010 | 4100533 | F | 3 | 4369010-7 | 20030101 | 20040513 | 20040525 | EXP | 2003-BP-10772BP | B.I. PHARMACEUTICALS, INC./RIDGEFIELD DRUG SURVEILLANCE AND | 95 | YR | F | N | 20040524 |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4369010 | 1004909734 | PS | CATAPRES-TTS-3 | 1 | ORAL | 0.2 MG (5 MG, 1 PATCH Q WEEK), PO | D | D | 18891 | ||
| 4369010 | 1004923087 | C | LASIX | 1 | |||||||
| 4369010 | 1004923088 | C | PLAVIX | 1 | |||||||
| 4369010 | 1004923090 | C | LOPRESSOR | 1 | |||||||
| 4369010 | 1004923091 | C | ACETYLSALICYLIC ACID SRT | 1 | |||||||
| 4369010 | 1004923092 | C | CARDIZEM | 1 | |||||||
| 4369010 | 1004923093 | C | SYNTHROID | 1 | |||||||
| 4369010 | 1004923094 | C | VICODIN | 1 | |||||||
| 4369010 | 1004923096 | C | DILANTIN | 1 | |||||||
| 4369010 | 1004923097 | C | NORVASC | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4369010 | 1004909734 | HYPERTENSION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4369010 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4369010 | CEREBROVASCULAR ACCIDENT |
| 4369010 | CONVULSION |
| 4369010 | HYPERTENSION |
| 4369010 | INFECTION |
| 4369010 | OEDEMA PERIPHERAL |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 4369010 | CSM |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4369010 | 1004909734 | 20030101 |